Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008

被引：105

作者：

Furst, D. E. ^{[1
]}

Keystone, E. C. ^{[1
]}

Kirkham, B. ^{[1
]}

Fleischmann, R. ^{[1
]}

Mease, P. ^{[1
]}

Breedveld, F. C. ^{[1
]}

Smolen, J. S. ^{[1
]}

Kalden, J. R. ^{[1
]}

Burmester, G. R. ^{[1
]}

Braun, J. ^{[1
]}

Emery, P. ^{[1
]}

Winthrop, K. ^{[1
]}

Bresnihan, B. ^{[1
]}

De Benedetti, F. ^{[1
]}

Doerner, T. ^{[1
]}

Gibofsky, A. ^{[1
]}

Schiff, M. H. ^{[1
]}

Sieper, J. ^{[1
]}

Singer, N. ^{[1
]}

Van Riel, P. L. C. M. ^{[1
]}

Weinblatt, M. E. ^{[1
]}

Weisman, M. H. ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90025 USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2008年 / 67卷

关键词：

D O I：

10.1136/ard.2008.100834

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2 / 25

页数：24

共 488 条

[91]

Cohen G, 2005, CLIN EXP RHEUMATOL, V23, P795

[92]

COHEN SB, 2005, ARTHRITIS RHEUM, V52, P1830

[93] Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks [J].

Cohen, Stanley B. ;

Emery, Paul ;

Greenwald, Maria W. ;

Dougados, Maxime ;

Furie, Richard A. ;

Genovese, Mark C. ;

Keystone, Edward C. ;

Loveless, James E. ;

Burmester, Gerd-Ruediger ;

Cravets, Matthew W. ;

Hessey, Eva W. ;

Shaw, Timothy ;

Totoritis, Mark C. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :2793-2806

[94]

COMBE B, 2007, ARTHRITIS RHEUM S, V46, pS519

[95] Abnormal production of the tumor necrosis factor inhibitor etanercept and clinical efficacy of tumor in a patient with PAPA syndrome [J].

Cortis, E ;

De Benedetti, F ;

Insalaco, A ;

Cioschi, S ;

Muratori, F ;

D'Urbano, LE ;

Ugazio, AG .

JOURNAL OF PEDIATRICS, 2004, 145 (06) :851-855

[96] Improvement of refractory rheumatoid arthritis-associated constrictive bronchiolitis with etanercept [J].

Cortot, AB ;

Cottin, V ;

Miossec, P ;

Fauchon, E ;

Thivolet-Béjui, F ;

Cordier, JF .

RESPIRATORY MEDICINE, 2005, 99 (04) :511-514

[97]

Costamagna P., 2004, Morbidity and Mortality Weekly Report, V53, P683

[98] Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy [J].

Cravedi, Paolo ;

Ruggenenti, Piero ;

Sghirlanzoni, Maria Chiara ;

Remuzzi, Giuseppe .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (05) :932-937

[99] An open label study of the effects of rituximab in neuromyelitis optica [J].

Cree, BAC ;

Lamb, S ;

Morgan, K ;

Chen, A ;

Waubant, E ;

Genain, C .

NEUROLOGY, 2005, 64 (07) :1270-1272

[100]

Culy CR, 2002, DRUGS, V62, P2493

← 5 6 7 8 9 10 11 12 13 14 →